TY - JOUR
T1 - Non-small cell lung cancer
T2 - Clinical practice guidelines in oncology
AU - Ettinger, David S.
AU - Akerley, Wallace
AU - Borghaei, Hossein
AU - Chang, Andrew C.
AU - Cheney, Richard T.
AU - Chirieac, Lucian R.
AU - D'Amico, Thomas A.
AU - Demmy, Todd L.
AU - Ganti, Apar Kishor P.
AU - Govindan, Ramaswamy
AU - Grannis, Frederic W.
AU - Horn, Leora
AU - Jahan, Thierry M.
AU - Jahanzeb, Mohammad
AU - Kessinger, Anne
AU - Komaki, Ritsuko
AU - Kong, Feng Ming
AU - Kris, Mark G.
AU - Krug, Lee M.
AU - Lennes, Inga T.
AU - Loo, Billy W.
AU - Martins, Renato
AU - O'Malley, Janis
AU - Osarogiagbon, Raymond U.
AU - Otterson, Gregory A.
AU - Patel, Jyoti D.
AU - Pinder-Schenck, Mary C.
AU - Pisters, Katherine M.
AU - Reckamp, Karen
AU - Riely, Gregory J.
AU - Rohren, Eric
AU - Swanson, Scott J.
AU - Wood, Douglas E.
AU - Yang, Stephen C.
AU - Hughes, Miranda
AU - Gregory, Kristina M.
PY - 2012/10/1
Y1 - 2012/10/1
N2 - Most patients with non-small cell lung cancer (NSCLC) are diagnosed with advanced cancer. These guidelines only include information about stage IV NSCLC. Patients with widespread metastatic disease (stage IV) are candidates for systemic therapy, clinical trials, and/or palliative treatment. The goal is to identify patients with metastatic disease before initiating aggressive treatment, thus sparing these patients from unnecessary futile treatment. If metastatic disease is discovered during surgery, then extensive surgery is often aborted. Decisions about treatment should be based on multidisciplinary discussion.
AB - Most patients with non-small cell lung cancer (NSCLC) are diagnosed with advanced cancer. These guidelines only include information about stage IV NSCLC. Patients with widespread metastatic disease (stage IV) are candidates for systemic therapy, clinical trials, and/or palliative treatment. The goal is to identify patients with metastatic disease before initiating aggressive treatment, thus sparing these patients from unnecessary futile treatment. If metastatic disease is discovered during surgery, then extensive surgery is often aborted. Decisions about treatment should be based on multidisciplinary discussion.
UR - http://www.scopus.com/inward/record.url?scp=84870996017&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84870996017&partnerID=8YFLogxK
U2 - 10.6004/jnccn.2012.0130
DO - 10.6004/jnccn.2012.0130
M3 - Review article
C2 - 23054877
AN - SCOPUS:84870996017
SN - 1540-1405
VL - 10
SP - 1236
EP - 1271
JO - JNCCN Journal of the National Comprehensive Cancer Network
JF - JNCCN Journal of the National Comprehensive Cancer Network
IS - 10
ER -
